[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349121-105":59,"doc-detail-349121-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","mitochondrial-etf-insufficiency-drives-neoplastic-growth-by-selectively-optimizing-cancer-bioenergetics","Mitochondrial ETF insufficiency drives neoplastic growth by selectively optimizing cancer bioenergetics","","Mitochondrial electron transport flavoprotein (ETF) insufficiency underlies multiple acyl-CoA dehydrogenase deficiency (MADD), yet ETFDH is non-essential in acute lymphoblastic leukemia NALM6 cells and is downregulated across human cancers. In human cancer cell lines and mouse models, reduced ETFDH activity limits OXPHOS fuel flexibility while paradoxically enhancing bioenergetics and accelerating neoplastic growth. Mechanistically, ETF insufficiency drives mTORC1 activation through an amino-acid–linked BCL-6/4E-BP1 axis, enabling bioenergetic and signaling reprogramming.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mitochondrial-etf-insufficiency-drives-neoplastic-growth-by-selectively-optimizing-cancer-bioenergetics/349121/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mitochondrial-etf-insufficiency-drives-neoplastic-growth-by-selectively-optimizing-cancer-bioenergetics/349121.png","ImageObject",300,407,{"name":92,"@type":93},"Rizky","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What does mitochondrial ETF insufficiency do in cancer models?","Question",{"text":113,"@type":114},"ETF insufficiency caused by decreased ETFDH activity enhances bioenergetics and accelerates neoplastic growth in human cancer cell lines and mouse models.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How is the effect on growth mediated mechanistically?",{"text":118,"@type":114},"The document links ETF insufficiency to mTORC1 activation via an amino-acid–impacting signaling pathway described as the BCL-6/4E-BP1 axis.",{"name":120,"@type":111,"acceptedAnswer":121},"Why is ETFDH downregulation considered paradoxical?",{"text":122,"@type":114},"Although ETFDH downregulation reduces flexibility of OXPHOS fuel utilization, it paradoxically increases bioenergetic capacity and promotes neoplastic growth.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},349121,1790520665,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962085564807,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","RESEARCH ARTICLE  \n*For correspondence:  \ndavid.papadopoli@mail.mcgill. ca (DP);  \n[michael.pollak@mcgill.ca](michael.pollak@mcgill.ca) (MP); [ivan.topisirovic@mcgill.ca](ivan.topisirovic@mcgill.ca) (IT)  \nCompeting interest: See page 23  \nFunding: See page 23  \nPreprint posted  \n22 February 2025  \nSent for Review  \n03 March 2025  \nReviewed preprint posted  \n09 May 2025  \nReviewed preprint revised  \n17 February 2026  \nVersion of Record published  \n05 May 2026  \nReviewing Editor: Dudley W Lamming, University of Wisconsin-Madison, United States  \n Copyright Papadopoli et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.  \nMitochondrial ETF insufficiency drives neoplastic growth by selectively optimizing cancer bioenergetics  \nDavid Papadopoli1,2*, Ranveer Palia1,3, Predrag Jovanovic1,3, Sébastien Tabariès4, Emma Ciccolini1,3, Valerie Sabourin1, Sebastian Igelmann5, Shannon McLaughlan6, Lesley Zhan6, HaEun Kim3, Nabila Chekkal6, Krzysztof J Szkop7,  \nThierry Bertomeu8, Jibin Zeng1, Julia Vassalakis9, Farzaneh Afzali9, Slim Mzoughi10, Ernesto Guccione10, Mike Tyers11,12, Daina Avizonis4,13, Ola Larsson7,  \nLynne-Marie Postovit9, Sergej Djuranovic14,15, Josie Ursini-Siegel1,2,3,6, Peter M Siegel3,4,6, Michael Pollak1,2,3*, Ivan Topisirovic2,3,6*  \n1 Lady Davis Institute, SMBD JGH, McGill University, Montréal, Canada; 2Gerald Bronfman Department of Oncology, McGill University, Montréal, Canada; 3 Department of Experimental Medicine, McGill University, Montréal, Canada; 4 Rosalind and Morris Goodman Cancer Institute, McGill University, Montréal, Canada; 5VIB Center for Cancer Biology, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium; 6 Department of Biochemistry, McGill University, Montréal, Canada; 7 Department of Oncology-Pathology, Science for  \nLife Laboratory, Karolinska Institute, Stockholm, Sweden; 8 Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada; 9 Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada; 10Center of OncoGenomics and Innovative Therapeutics (COGIT), Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, United States; 11 Program in Molecular Medicine, The Hospital for Sick Children, Toronto, Canada; 12 Department of Molecular Genetics, University of Toronto, Toronto, Canada; 13 Metabolomics Innovation Resource, McGill University, Montréal, Canada; 14 Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, United States; 15 Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, United States  \neLife Assessment  \nThe authors present an important set of data implicating ETFDH as an epigenetically suppressed gene in cancer with tumor suppressive functions. The evidence is convincing, with the authors demonstrating that suppression of ETFDH activity results in accumulation of amino acids that impact metabolism via hyperactive mTORC1 .  \nAbstract Mitochondrial electron transport flavoprotein (ETF) insufficiency causes metabolic diseases known as a multiple acyl-CoA dehydrogenase deficiency (MADD) . In contrast to muscle, ETFDH is a non-essential gene in acute lymphoblastic leukemia NALM6 cells, and its expression is reduced across human cancers. In various human cancer cell lines and mouse models, ETF insufficiency caused by decreased ETFDH expression limits flexibility of OXPHOS fuel utilisation but paradoxically increases bioenergetics and accelerates neoplastic growth via activation of the mTORC1/  \nPapadopoli et al. eLife 2025;14:RP106587. DOI: [https://doi.org/10.7554/eLife.106587](https://doi.org/10.7554/eLife.106587) 1 of 28  \n Research article Cancer Biology | Cell Biology  \nBCL-6/4E-BP1 axis. Collectively, these findin","cbCaidvLYVzUzu8Z","https://ap.wps.com/l/cbCaidvLYVzUzu8Z","pdf",1860383,28,"English","# Introduction\n## Results\n### ETFDH abrogation accelerates tumor growth","[{\"question\":\"What does mitochondrial ETF insufficiency do in cancer models?\",\"answer\":\"ETF insufficiency caused by decreased ETFDH activity enhances bioenergetics and accelerates neoplastic growth in human cancer cell lines and mouse models.\"},{\"question\":\"How is the effect on growth mediated mechanistically?\",\"answer\":\"The document links ETF insufficiency to mTORC1 activation via an amino-acid–impacting signaling pathway described as the BCL-6/4E-BP1 axis.\"},{\"question\":\"Why is ETFDH downregulation considered paradoxical?\",\"answer\":\"Although ETFDH downregulation reduces flexibility of OXPHOS fuel utilization, it paradoxically increases bioenergetic capacity and promotes neoplastic growth.\"}]","Mitochondrial ETF insufficiency drives neoplastic growth by selectively optimizing cancer bioenergetics | PDF",1790081745,71,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c285de24efa705eb02ad27480f66f031.webp",983,1272,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/158d966c46412d51536d1e359ac5b51c.webp",982,1270,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/65d34e0030b073a606f13a010b3ea73f.webp",981,1269,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a6732c5ea56b3add5159c00b2d54a11f.webp",980,1268]